Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Molecular Effects of N-Acetylcysteine Treatment in COVID-19-Related Acute Respiratory Distress Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study

NCT07374991 is registered in ClinicalTrials.gov with University of Gaziantep as lead sponsor.

NCT NCT07374991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07374991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Molecular Effects of N-Acetylcysteine Treatment in COVID-19-Related Acute Respiratory Distress Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study
Lead sponsor
University of Gaziantep
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2020
Completion date
October 10, 2022
Enrollment
59 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19-associated acute respiratory distress syndrome (ards)